Literature DB >> 16965724

Expanding the definition of hypertension to incorporate global cardiovascular risk.

Nitin Khosla1, Henry R Black.   

Abstract

Recent epidemiologic analyses have changed the way that hypertension is viewed. Cardiovascular risk has been found to be elevated at levels of blood pressure previously believed to be normal and not imparting additional risk. Furthermore, the approach to hypertension has been shifted from viewing and treating it in isolation to a more comprehensive approach that incorporates a focus on global cardiovascular risk and the risk factors commonly associated with having an elevated blood pressure. However, control rates not only for hypertension but also for associated risk factors, such as hyperlipidemia and diabetes, remain abysmal, providing an even greater challenge to providers of care. To change this alarming trend, physicians must become aggressive in using the available armamentarium of lifestyle modifications and drugs in treating hypertension and other risk factors that increase the burden of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965724     DOI: 10.1007/s11906-006-0082-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  42 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  J curve in hypertension and coronary artery disease.

Authors:  Franz H Messerli; Stuart Kupfer; Carl J Pepine
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

Review 4.  Endothelial dysfunction and pathogenesis of diabetic angiopathy.

Authors:  C D Stehouwer; J Lambert; A J Donker; V W van Hinsbergh
Journal:  Cardiovasc Res       Date:  1997-04       Impact factor: 10.787

Review 5.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Richard Kahn; John Buse; Ele Ferrannini; Michael Stern
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

6.  Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists.

Authors:  M R Weir; C Rosenberger; J C Fink
Journal:  Am J Hypertens       Date:  2001-09       Impact factor: 2.689

Review 7.  Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.

Authors:  E L Schiffrin; L Y Deng; P Larochelle
Journal:  J Cardiovasc Pharmacol       Date:  1994       Impact factor: 3.105

8.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

Review 9.  Microalbuminuria. Implications for micro- and macrovascular disease.

Authors:  T Deckert; A Kofoed-Enevoldsen; K Nørgaard; K Borch-Johnsen; B Feldt-Rasmussen; T Jensen
Journal:  Diabetes Care       Date:  1992-09       Impact factor: 19.112

10.  The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?

Authors:  L Farnett; C D Mulrow; W D Linn; C R Lucey; M R Tuley
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.